Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
- # Reduced-intensity Conditioning Hematopoietic Stem Cell Transplantation
- # Minor ABO Incompatibility
- # Allogeneic Hematopoietic Stem Cell Transplantation
- # PubMed Scopus
- # Reduced-intensity Conditioning Regimens
- # 3-year Probability Of Overall Survival
- # Allogeneic Transplantation
- # Conditioning Regimen
- # Allogeneic Blood Stem Cell Transplantation
- # Anti-thymocyte Globulins
- Research Article
31
- 10.1016/j.exphem.2012.06.003
- Jun 12, 2012
- Experimental Hematology
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens
- Research Article
41
- 10.1016/j.bbmt.2009.09.020
- Sep 26, 2009
- Biology of Blood and Marrow Transplantation
Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
- Research Article
17
- 10.1016/j.exphem.2013.09.012
- Oct 2, 2013
- Experimental Hematology
Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma
- Research Article
33
- 10.1016/j.bbmt.2010.10.031
- Nov 1, 2010
- Biology of Blood and Marrow Transplantation
Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
- Research Article
20
- 10.1016/j.bbmt.2011.04.009
- Apr 27, 2011
- Biology of Blood and Marrow Transplantation
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients
- Discussion
- 10.1016/j.bbmt.2018.08.014
- Aug 18, 2018
- Biology of Blood and Marrow Transplantation
It's Not All in the Conditioning or the Perils of Early Trial Cessation
- Research Article
29
- 10.1016/j.bbmt.2011.06.010
- Jun 30, 2011
- Biology of Blood and Marrow Transplantation
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
- Research Article
100
- 10.1016/j.bbmt.2010.05.007
- May 26, 2010
- Biology of Blood and Marrow Transplantation
Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- Research Article
30
- 10.1016/j.bbmt.2012.04.002
- Apr 5, 2012
- Biology of Blood and Marrow Transplantation
Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable
- Research Article
11
- 10.1016/j.exphem.2005.04.009
- Jul 20, 2005
- Experimental Hematology
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability
- Research Article
131
- 10.1016/j.bbmt.2008.08.006
- Oct 17, 2008
- Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)
- Research Article
55
- 10.1016/j.bbmt.2011.07.012
- Jul 23, 2011
- Biology of Blood and Marrow Transplantation
Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
- Research Article
34
- 10.1016/j.bbmt.2011.05.015
- May 27, 2011
- Biology of Blood and Marrow Transplantation
CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus
- Research Article
21
- 10.1016/j.bbmt.2012.10.028
- Oct 27, 2012
- Biology of Blood and Marrow Transplantation
Graft-versus-Host Disease: State of the Science
- Discussion
3
- 10.1016/j.bbmt.2009.02.012
- May 14, 2009
- Biology of Blood and Marrow Transplantation
Defining Conditioning Regimens for BMT—Recognition of “Regimens of Intermediate Intensity”